Autopsy report · NCT02195310

The Use of PrevenaTM on Clean Closed Sternal Midline Incisions in Subjects at High Risk for Surgical Site Occurrences.

“due to futility”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months after it had already started.
• Ran for about 2 years 11 months before it stopped.
• 342 participants enrolled.
• Results were posted on the registry 2 years 10 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Solventum US LLC

Sponsor type

Industry

Conditions

Surgical Site Occurences After Sternotomy; Wound Infection

Interventions

Prevena™ Incision Management System; Conventional sterile wound dressings

Participants

342

Sites

13

Countries

Austria, Germany, Netherlands

Trials that died the same way

• Radiation Post-CAR T in Refractory Lymphoma
  “Futility” (78% match in meaning)
• Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection
  “for futility” (76% match in meaning)
• Prevention of Unexplained Recurrent Abortion by Enoxaparine
  “Stopped for futility” (67% match in meaning)
• The Effectiveness of Non-Pyrethroid Insecticide-Treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural Tanzania
  “futility ground” (61% match in meaning)
• Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
  “Due to business reasons” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.